Review
Published on 05 Nov 2025
Durvalumab consolidation therapy in patients with stage III small cell lung cancer after concurrent chemoradiation: a China-based cost-effectiveness analysis
in Cancer Immunity and Immunotherapy
- 537 views
Review
Published on 05 Nov 2025
in Cancer Immunity and Immunotherapy
Systematic Review
Published on 05 Nov 2025
in Intensive Care Medicine and Anesthesiology
Original Research
Published on 05 Nov 2025
in International Studies
Review
Published on 05 Nov 2025
in Neonatology
Systematic Review
Published on 05 Nov 2025
in Stroke
Original Research
Published on 05 Nov 2025
in Movement Science
Original Research
Published on 05 Nov 2025
in Infectious Diseases: Pathogenesis and Therapy
Original Research
Published on 05 Nov 2025
in Forest Management
Review
Published on 05 Nov 2025
in Translational and Clinical Endocrinology
Review
Published on 05 Nov 2025
in Pediatric Psychology
Opinion
Published on 05 Nov 2025
in Family Medicine and Primary Care
Original Research
Published on 05 Nov 2025
in Plant Systematics and Evolution
Original Research
Published on 05 Nov 2025
in Neuro-Otology
Case Report
Published on 05 Nov 2025
in Neuro-Oncology and Neurosurgical Oncology
Original Research
Published on 05 Nov 2025
in Teacher Education
Review
Published on 05 Nov 2025
in Addictive Disorders